Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center

Journal of Cystic Fibrosis

Volumn 3, Issue 3, 2004, Pages 159-163

  Campana, Silvia ^a   Taccetti, Giovanni ^a   Ravenni, Novella ^a   Masi, Isabella ^a   Audino, Sandra ^a   Sisi, Barbara ^a   Repetto, Teresa ^a   Döring, Gerd ^b   de Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bacterial isolate; Cystic fibrosis; Pulmonary infection

Indexed keywords

CIPROFLOXACIN; COLISTIN;

ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CHRONIC DISEASE; CONTROLLED STUDY; CROSS INFECTION; CYSTIC FIBROSIS; GENOTYPE; GRAM NEGATIVE INFECTION; HEALTH CARE FACILITY; HOSPITAL; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; ITALY; LUNG INFECTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION MAPPING; RISK REDUCTION; SOURCE SINK RELATIONSHIP; STAPHYLOCOCCUS INFECTION; STRAIN IDENTIFICATION;

ADOLESCENT; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HUMANS; METHICILLIN RESISTANCE; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 4444279595     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2004.03.010     Document Type: Article

References (35)

1. Lewis P.A. The epidemiology of cystic fibrosis, In: Hodson M.E. Geddes D. (Eds.). Cystic Fibrosis 1995 Chapmen and Hall London
2. Santis G. Basic molecular biology, In: Hodson M.E. Geddes D. (Eds.). Cystic Fibrosis 1995 Chapman & Hall London
3. Sheppard M.N. The pathology of cystic fibrosis, In: Hodson M.E. Geddes D. (Eds.). Cystic Fibrosis 1995 Chapman and Hall London
4. Cystic Fibrosis Foundation Cystic Fibrosis Foundation Patient Registry 1997 Annual Data Report 1998 Cystic Fibrosis Foundation Bethesda, MD, USA
5. Høiby N. Microbiology of CF, In: Hodson M.E. Geddes D. (Eds.) Cystic Fibrosis 1995 Chapman and Hall London
6. Thomas S.R. Guy K.M. Gaya H. Hodson M.E. Methicillin-resistant Staphylococcus aureus: Impact at a national cystic fibrosis J. Hosp. Infect. 40 1998 203-209
7. Tablan O.C. Martone W.J. Doershuk C.F. et al. Colonisation of the respiratory tract with Pseudomonas cepacia in cystic fibrosis, Risk factors and outcomes Chest 91 1987 527-532
8. Döring G. Schaffar L. Epidemiology of pulmonary infection by Pseudomonas in patients with cystic fibrosis: A consensus report 1993 Association Francaise de Lutte contre la mucoviscidose (AFLM) Paris
9. Govan J.R.W.B. Brown P.H. Maddison J. et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis Lancet 342 1993 15-19
10. Smith D.L. Gumery L.B. Smith E.G. Stableforth D.E. Kaufmann M.E. Pitt T.L. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: Evidence of person to person transmission J. Clin. Microbiol. 31 1993 3017-3022
11. Sun L. Jiang R. Steinbach S. et al. The emergence of a highly transmissible lineage of abl + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain Nat. Med. 1 1995 661-665
12. Stern M, Döring G, Eißing G, et al. Qualitätssicherung Mukoviszidose. Zentrum für Qualitätsmanagement im Gesundheitswesen. Ärztekammer Niedersachsen, Postfach 4749, 30047 Hannover
13. Botzenhart K. Döring G. Epidemiology and ecology of Pseudomonas aeruginosa, In: Campa M. Bandinelli M. Friedman H. (Eds.). Pseudomonas aeruginosa as an opportunistic pathogen 1993 1-18 Plenum Publishing New York
14. Döring G. Jansen S. Noll H. et al. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward Pediatr. Pulmonol. 21 1996 90-100
15. Goerke C. Kraning K. Stern M. Döring G. Botzenhart K. Wolz C. Molecular epidemiology of community-acquired Staphylococcus aureus in families with and without cystic fibrosis patients J. Infect. Dis. 181 2000 984-989
16. Høiby N. Koch C. Pseudomonas aeruginosa infection in cystic fibrosis and its management Thorax 45 1990 881-884
17. Ojeniyi B. Stenn Pedersen U. Høiby N. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients APMIS 101 1993 168-175
18. Grundmann H. Schneider C. Hartung D. Daschner F.D. Pitt T.L. Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa J. Clin. Microbiol. 33 1995 528-534
19. Ichiyama S. Ohta M. Shimokata K. Kato N. Takeuchi J. Genomic fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus J. Clin. Microbiol. 29 1991 2690-2695
20. Anderson D.J. Kuhns J.S. Vasil M.L. Gerding D.N. Janoff E.N. DNA fingerprinting by pulsed field gel electrophoresis and rybotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak J. Clin. Microbiol. 29 1991 648-649
21. Grothues D. Koopmann U. von der Hardt H. Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains J. Clin. Microbiol. 26 1988 1973-1977
22. Tenover F.C. Arbeit R.D. Goering R.V. et al. Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: Criteria for bacterial strain typing J. Clin. Microbiol. 33 1995 2233-2239
23. Saiman L. Siegel J. Cystic Fibrosis Foundation Consesus Conference of Infection Control Participants Am. J. Infect. Control 31 3 Suppl 2003 S1-S62
24. Döring G. Conway S.P. Heijerman H.G.M. et al. for the Consensus Committee Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: A European consensus Eur. Respir. J. 16 2000 749-767
25. Tümmler B. Koopmann U. Grothues D. Weissbrodt H. Steinkamp G. Vonderhardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients J. Clin. Microbiol. 29 1991 126-1267
26. MacCallum S.J. Corkill J. Gallagher M. Ledson M.J. Hart C.A. Walshaw M.J. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonized by Pseudomonas aeruginosa Lancet 358 2001 558-560
27. Jones A.M. Govan J.R.W. Doherty C.J. et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in a adult cystic fibrosis clinic Lancet 358 2001 557-558
28. Pedersen S.S. Koch C. Høiby N. Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis center J. Antimicrob. Chemother. 17 1986 505-516
29. Armstrong D.S. Carzino R. Carlin J. Nixon G. Grimwood K. Long-term outbreak of a transmissible virulent strain of Pseudomonas aeruginosa in a paediatric cystic fibrosis clinic Pediatr. Pulmonol., Suppl. 20 2000 285
30. Wolz C. Kiosz G. Ogle J.W. et al. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis: Use of a DNA probe Epidemiol. Infect. 102 1989 205-214
31. Döring G. Ulrich M. Müller W. et al. Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device Z. Hyg. 191 1991 494-505
32. Speert D.P. Campbell M.E. Henry D.A. et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada Am. J. Respir. Crit. Care Med. 166 2002 988-993
33. Mahenthiralingam E. Campbell M.E. Henry D.A. Speert D.P. Epidemiology of Burkholderia cepacia infection in patient with cystic fibrosis: Analysis by randomly amplified polymorphic DNA fingerprinting J. Clin. Microbiol. 34 1996 2914-2920
34. Miall L.S. McGinley N.T. Brownlee K.G. Conway S.P. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis Arch. Dis. Child. 84 2001 160-162
35. Givney R. Vickery A. Holliday A. Pegler M. Benn R. Methicillin-resistant Staphylococcus aureus in a cystic fibrosis unit J. Hosp. Infect. 35 1997 27-36